Lamivudine (Synonyms: (-)-BCH 189, 3TC, 2’,3’-dideoxy-3’-Thiacytidine) |
カタログ番号GC10317 |
ラミブジン (BCH-189) は、経口で活性なヌクレオシド系逆転写酵素阻害剤 (NRTI) です。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 134678-17-4
Sample solution is provided at 25 µL, 10mM.
Lamivudine (BCH-189) is a nucleoside reverse transcriptase inhibitors (NRTIs). Lamivudine (BCH-189) can inhibit HIV reverse transcriptase 1/2 and also the reverse transcriptase of hepatitis B virus.
References:
[1]. Li, Y.C., [A clinical study on lamivudine treatment for advanced schistosomisis with chronic B hepatits]. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, 2013. 25(5): p. 548-9, 551.
[2]. Zhang, C.E., et al., [Effects of lamivudine on growth of intestinal characteristic bacteria by microcalorimetry in vitro]. Yao Xue Xue Bao, 2013. 48(10): p. 1590-4.
Average Rating: 5
(Based on Reviews and 19 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *